ACHE and early-onset autosomal dominant Alzheimer disease: Currently, one of the most acute health conditions among ageing populations worldwide is Alzheimer’s disease, and for this reason, the inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) currently form the basis of the newest drugs available for management of this disease.